Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

World Birth Defects Day.

Groisman B, Bidondo MP, Piola A, Tellechea AL, Barbero P, Liascovich R.

Arch Argent Pediatr. 2019 Oct 1;117(5):284-285. doi: 10.5546/aap.2019.eng.284. No abstract available.

2.

[Birth prevalence of Down syndrome in Argentina].

Martini J, Bidondo MP, Duarte S, Liascovich R, Barbero P, Groisman B.

Salud Colect. 2019 Jul 29;15:e1863. doi: 10.18294/sc.2019.1863. Spanish.

PMID:
31365691
3.

[Lumbocostovertebral syndrome: first case report in Argentina].

Albarracín MLA, Groisman B, Liascovich R, Barbero P, Bidondo MP.

Arch Argent Pediatr. 2019 Aug 1;117(4):e377-e381. doi: 10.5546/aap.2019.e377. Spanish.

4.

Hepatitis A outbreak affecting men who have sex with men (MSM) in central Argentina, occurred in July 2017-April 2018, later than the European outbreak.

Mariojoules J, Castro G, Pisano MB, Barbero P, Fantilli A, Borda M, Canna F, Barbás G, Ré V.

J Clin Virol. 2019 Aug;117:49-53. doi: 10.1016/j.jcv.2019.05.014. Epub 2019 May 31.

PMID:
31202104
5.

[Systems for surveillance of birth defects in Latin America and the Caribbean: present and futureSistemas de vigilância de anomalias congênitas na América Latina e Caribe: presente e futuro].

Durán P, Liascovich R, Barbero P, Bidondo MP, Groisman B, Serruya S, de Francisco LA, Becerra-Posada F, Gordillo-Tobar A.

Rev Panam Salud Publica. 2019 May 24;43:e44. doi: 10.26633/RPSP.2019.44. eCollection 2019. Spanish.

6.

Transcriptomic analysis of Spodoptera frugiperda Sf9 cells resistant to Bacillus thuringiensis Cry1Ca toxin reveals that extracellular Ca2+, Mg2+ and production of cAMP are involved in toxicity.

Castella C, Pauron D, Hilliou F, Trang VT, Zucchini-Pascal N, Gallet A, Barbero P.

Biol Open. 2019 Apr 18;8(4). pii: bio037085. doi: 10.1242/bio.037085.

7.

Application of quality indicators to data from the National Network of Congenital Anomalies of Argentina.

Groisman B, Barbero P, Mastroiacovo P, Botto LD, Bidondo MP, Liascovich R.

Birth Defects Res. 2019 Apr 1;111(6):333-340. doi: 10.1002/bdr2.1472. Epub 2019 Feb 13.

PMID:
30756506
8.

A proposal for the systematic assessment of data quality indicators in birth defects surveillance.

Groisman B, Mastroiacovo P, Barbero P, Bidondo MP, Liascovich R, Botto LD.

Birth Defects Res. 2019 Apr 1;111(6):324-332. doi: 10.1002/bdr2.1474. Epub 2019 Feb 11.

PMID:
30746866
9.

[Analysis on risk factors associated with birth defects in newborns in the area of the Matanza-Riachuelo river basin.]

Bidondo MP, Groisman B, Gili JA, Liascovich R, Martin MC, Tocci A, Flores R, Pus Barraza A, Barbero P.

Rev Fac Cien Med Univ Nac Cordoba. 2018 Dec 13;75(4):261-269. doi: 10.31053/1853.0605.v75.n4.20284. Spanish.

PMID:
30734705
10.

Birth defects surveillance: experiences in Argentina and Colombia.

Groisman B, Liascovich R, Bidondo MP, Barbero P, Duarte S, Tellechea AL, Holguín J, Rodríguez C, Hurtado-Villa P, Caicedo N, Botta G, Zarante I.

J Community Genet. 2019 Jul;10(3):385-393. doi: 10.1007/s12687-018-00403-6. Epub 2019 Jan 3.

11.

Bone dysplasias in 1.6 million births in Argentina.

Duarte SP, Rocha ME, Bidondo MP, Liascovich R, Barbero P, Groisman B.

Eur J Med Genet. 2018 Dec 17. pii: S1769-7212(18)30593-7. doi: 10.1016/j.ejmg.2018.12.008. [Epub ahead of print]

PMID:
30572171
12.

Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study.

Artusi CA, Bortolani S, Merola A, Zibetti M, Busso M, De Mercanti S, Arnoffi P, Martinetto S, Gaidolfi E, Veltri A, Barbero P, Lopiano L.

Parkinsonism Relat Disord. 2019 May;62:231-235. doi: 10.1016/j.parkreldis.2018.11.003. Epub 2018 Nov 5.

PMID:
30442481
13.

Genetic Imbalances in Argentinean Patients with Congenital Conotruncal Heart Defects.

Delea M, Espeche LD, Bruque CD, Bidondo MP, Massara LS, Oliveri J, Brun P, Cosentino VR, Martinoli C, Tolaba N, Picon C, Ponce Zaldua ME, Ávila S, Gutnisky V, Perez M, Furforo L, Buzzalino ND, Liascovich R, Groisman B, Rittler M, Rozental S, Barbero P, Dain L.

Genes (Basel). 2018 Sep 11;9(9). pii: E454. doi: 10.3390/genes9090454.

14.

[Descriptive epidemiology of major structural congenital anomalies in Argentina].

Groisman B, Bidondo MP, Duarte S, Tardivo A, Barbero P, Liascovich R.

Medicina (B Aires). 2018;78(4):252-257. Spanish.

15.

Surveillance of microcephaly and selected brain anomalies in Argentina: Relationship with Zika virus and other congenital infections.

Tellechea AL, Luppo V, Morales MA, Groisman B, Baricalla A, Fabbri C, Sinchi A, Alonso A, Gonzalez C, Ledesma B, Masi P, Silva M, Israilev A, Rocha M, Quaglia M, Bidondo MP, Liascovich R, Barbero P; RENAC Task Force.

Birth Defects Res. 2018 Jul 17;110(12):1016-1026. doi: 10.1002/bdr2.1347. Epub 2018 Jun 19.

PMID:
29921033
16.

Lung adenocarcinoma during pregnancy: clinical case and literature review.

Bellido C, Barbero P, Forcén L, Blanco M, Alonso-Riaño M, Galindo A.

J Matern Fetal Neonatal Med. 2019 Oct;32(19):3300-3302. doi: 10.1080/14767058.2018.1461830. Epub 2018 Apr 18.

PMID:
29618241
17.

National Health Care Network for children with oral clefts: organization, functioning, and preliminary outcomes.

Cassinelli A, Pauselli N, Piola A, Martinelli C, Alves de Azeved JL, Bidondo MP, Groisman B, Barbero P, Liascovich R, Sala A.

Arch Argent Pediatr. 2018 Feb 1;116(1):e26-e33. doi: 10.5546/aap.2018.eng.e26. English, Spanish.

18.

Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.

Clerico M, Artusi CA, Di Liberto A, Rolla S, Bardina V, Barbero P, De Mercanti SF, Durelli L.

Expert Opin Drug Saf. 2017 Aug;16(8):963-972. doi: 10.1080/14740338.2017.1346082. Epub 2017 Jul 5. Review.

PMID:
28641055
19.

Natalizumab in Multiple Sclerosis: Long-Term Management.

Clerico M, Artusi CA, Liberto AD, Rolla S, Bardina V, Barbero P, Mercanti SF, Durelli L.

Int J Mol Sci. 2017 Apr 29;18(5). pii: E940. doi: 10.3390/ijms18050940. Review.

20.

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea.

Barbero P, Busso M, Artusi CA, De Mercanti S, Tinivella M, Veltri A, Durelli L, Clerico M.

J Vis Exp. 2016 Nov 9;(117). doi: 10.3791/54606.

21.

Diprosopus: Systematic review and report of two cases.

Bidondo MP, Groisman B, Tardivo A, Tomasoni F, Tejeiro V, Camacho I, Vilas M, Liascovich R, Barbero P.

Birth Defects Res A Clin Mol Teratol. 2016 Dec;106(12):993-1007. doi: 10.1002/bdra.23549. Epub 2016 Oct 5. Review.

PMID:
27704687
22.

Geographic clusters of congenital anomalies in Argentina.

Groisman B, Gili J, Giménez L, Poletta F, Bidondo MP, Barbero P, Liascovich R, López-Camelo J.

J Community Genet. 2017 Jan;8(1):1-7. doi: 10.1007/s12687-016-0276-2. Epub 2016 Aug 19.

23.

The National Network of Congenital Anomalies: extended goals for surveillance.

Groisman B, Bidondo MP, Barbero P, Liascovich R.

Arch Argent Pediatr. 2016 Aug 1;114(4):295-7. doi: 10.5546/aap.2016.295. Epub 2016 Jun 30. English, Spanish. No abstract available.

24.

Sirenomelia in Argentina: Prevalence, geographic clusters and temporal trends analysis.

Groisman B, Liascovich R, Gili JA, Barbero P, Bidondo MP; RENAC Task Force.

Birth Defects Res A Clin Mol Teratol. 2016 Jul;106(7):604-11. doi: 10.1002/bdra.23501. Epub 2016 Apr 8.

PMID:
27062024
25.

[Prevalence of neural tube defects and estimation of cases averted in the post-fortification period in Argentina].

Bidondo MP, Liascovich R, Barbero P, Groisman B.

Arch Argent Pediatr. 2015 Dec 1;113(6):498-501. Spanish.

26.

Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.

Barbero P, Busso M, Tinivella M, Artusi CA, De Mercanti S, Cucci A, Veltri A, Avagnina P, Calvo A, Chio' A, Durelli L, Clerico M.

J Neurol. 2015 Dec;262(12):2662-7. doi: 10.1007/s00415-015-7894-1. Epub 2015 Sep 26.

PMID:
26410746
27.

[Acheiropodia: first case report in Argentina].

Ormazabal M, Vaccari N, Szulepa R, Bidondo MP, Barbero P, Groisman B.

Arch Argent Pediatr. 2015 Oct;113(5):e299-303. doi: 10.5546/aap.2015.e299. Spanish.

28.

Study on the prevalence and neonatal lethality in patients with selected congenital anomalies as per the data of the National Registry of Congenital Anomalies of Argentina.

Bidondo MP, Groisman B, Gili JA, Liascovich R, Barbero P, Pingray V; RENAC Task Force.

Arch Argent Pediatr. 2015 Aug;113(4):295-302. doi: 10.5546/aap.2015.295. English, Spanish.

29.

Descriptive study on neural tube defects in Argentina.

Sargiotto C, Bidondo MP, Liascovich R, Barbero P, Groisman B.

Birth Defects Res A Clin Mol Teratol. 2015 Jun;103(6):509-16. doi: 10.1002/bdra.23372. Epub 2015 Apr 8.

PMID:
25855266
30.

Public health approach to birth defects: the Argentine experience.

Bidondo MP, Groisman B, Barbero P, Liascovich R.

J Community Genet. 2015 Apr;6(2):147-56. doi: 10.1007/s12687-014-0209-x. Epub 2015 Jan 7.

31.

Esophageal atresia and prenatal exposure to mycophenolate.

Martín MC, Cristiano E, Villanueva M, Bonora ML, Berguio N, Tocci A, Groisman B, Bidondo MP, Liascovich R, Barbero P.

Reprod Toxicol. 2014 Dec;50:117-21. doi: 10.1016/j.reprotox.2014.10.015. Epub 2014 Oct 25.

PMID:
25461910
32.

Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.

Martín MC, Barbero P, Groisman B, Aguirre MÁ, Koren G.

Reprod Toxicol. 2014 Jan;43:26-9.

PMID:
24513926
33.

[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].

Tomás-Vila M, Menor F, Ley-Martos M, Jumillas-Luján MJ, Marco-Hernández AV, Barbero P.

Rev Neurol. 2014 Feb 16;58(4):161-5. Spanish.

34.

RENAC: National Registry of Congenital Anomalies of Argentina.

Groisman B, Bidondo MP, Barbero P, Gili JA, Liascovich R; RENAC Task Force.

Arch Argent Pediatr. 2013 Dec;111(6):484-94. doi: 10.1590/S0325-00752013000600006. English, Spanish.

35.

Precise determination of strontium isotope ratios by TIMS to authenticate tomato geographical origin.

Trincherini PR, Baffi C, Barbero P, Pizzoglio E, Spalla S.

Food Chem. 2014 Feb 15;145:349-55. doi: 10.1016/j.foodchem.2013.08.030. Epub 2013 Aug 26.

PMID:
24128488
36.

Skin to skin after cesarean birth.

Barbero P, Madamangalam AS, Shields A.

J Hum Lact. 2013 Nov;29(4):446-8. doi: 10.1177/0890334413501287. No abstract available.

PMID:
24106020
37.

Strategies to achieve sustainability and quality in birth defects registries: the experience of the National Registry of Congenital Anomalies of Argentina.

Groisman B, Bidondo MP, Gili JA, Barbero P, Liascovich R.

J Registry Manag. 2013 Spring;40(1):29-31.

PMID:
23778694
38.

[Transient focal deficits in children with Sturge-Weber syndrome].

Tomás-Vila M, Menor-Serrano F, Arcos-Machancoses JV, García-Camuñas Y, Pitarch-Castellanos I, Barbero P.

Rev Neurol. 2013 Feb 16;56(4):253-5. Spanish. No abstract available.

39.

The use of a Toolkit for health needs assessment on neural tube defects in Argentina.

Groisman B, Liascovich R, Barbero P, Alberg C, Moorthie S, Nacul L, Sagoo GS.

J Community Genet. 2013 Jan;4(1):77-86. doi: 10.1007/s12687-012-0120-2. Epub 2012 Oct 4.

40.

Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina.

Pardon F, Vilariño M, Barbero P, Garcia G, Outon E, Gil C, Vera A, Rossi S, Distefano A.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S745-7. doi: 10.1093/infdis/jir442.

PMID:
21954276
41.

A laparoscopic approach to Nuck's duct endometriosis.

Jiménez JS, Barbero P, Tejerizo A, Guillén C, Strate C.

Fertil Steril. 2011 Aug;96(2):e103-5. doi: 10.1016/j.fertnstert.2011.05.083. Epub 2011 Jun 29.

PMID:
21719002
42.

Infection and immunity for human parvovirus B19 in patients with febrile exanthema.

Pedranti MS, Barbero P, Wolff C, Ghietto LM, Zapata M, Adamo MP.

Epidemiol Infect. 2012 Mar;140(3):454-61. doi: 10.1017/S0950268811000823. Epub 2011 May 18.

PMID:
21676356
43.

[Misoprostol teratogenicity: a prospective study in Argentina].

Barbero P, Liascovich R, Valdez R, Moresco A.

Arch Argent Pediatr. 2011 Jun;109(3):226-31. doi: 10.1590/S0325-00752011000300007. Spanish.

44.

Is endovascular revascularisation worthwhile in diabetic patients with critical limb ischemia who also have end-stage renal disease?

Rabellino M, Aragón-Sánchez J, González G, Zander T, Baldi S, Garcia-Nielsen L, Armas-Suarez S, Barbero P, Luis-Rodríguez D, Maynar M.

Diabetes Res Clin Pract. 2010 Dec;90(3):e79-81. doi: 10.1016/j.diabres.2010.09.021. Epub 2010 Oct 27.

PMID:
21030104
45.

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

Cucci A, Barbero P, Clerico M, Ferrero B, Versino E, Contessa G, Demercanti S, Viglietta E, Di Liberto A, Vai AG, Durelli L.

J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23.

PMID:
20573405
46.

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b.

Durelli L, Barbero P, Cucci A, Ferrero B, Ricci A, Contessa G, De Mercanti S, Ripellino P, Lapuma D, Viglietta E, Bergui M, Versino E, Clerico M; OPTIMS Trial NAb Sub-Study Group.

Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781 .

PMID:
19278300
47.

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.

Durelli L, Barbero P, Bergui M, Versino E, Bassano MA, Verdun E, Ferrero B, Rivoiro C, Ferrero C, Picco E, Ripellino P, Viglietti D, Giuliani G, Montanari E, Clerico M; OPTIMS Study Group.

J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25.

PMID:
18825438
48.

Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study.

Barbero P, Valdez R, Rodríguez H, Tiscornia C, Mansilla E, Allons A, Coll S, Liascovich R.

Am J Med Genet A. 2008 Sep 15;146A(18):2390-5. doi: 10.1002/ajmg.a.32497.

PMID:
18698631
49.

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis.

Durelli L, Barbero P, Bergui M, Versino E, Bassano MA, Verdun E, Rivoiro C, Ferrero C, Picco E, Ripellino P, Giuliani G, Montanari E, Clerico M; Italian Multiple Sclerosis Study Group.

J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51. Epub 2007 Nov 6.

PMID:
17986500
50.

[Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].

Rufino M, Barbero P, Hernández D, Torres A, Lorenzo V.

Nefrologia. 2007;27(1):30-7. Spanish.

Supplemental Content

Loading ...
Support Center